David Sholehvar serves as Executive at NEOGENOMICS INC, where they oversee executive responsibilities. Since joining the company, David Sholehvar has executed 3 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Nov 13, 2023 involved receiving (via award) 850,000 shares valued at $0.
David Sholehvar currently holds 850,000 shares of NEOGENOMICS INC (NEO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, David Sholehvar has been a net neutral trader of NEO stock. They have purchased $0 and sold $0 worth of shares.
David Sholehvar's most recent insider trade was on Nov 13, 2023, when they sold 850,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Apr 1, 2022 | NEO | $0 | Award | 30,864 | $N/A | Discretionary |